Trial intelligence / Profile preview

Xuesaitong Enteric-coated Tablets in Cerebral Infarction (Stroke Recovery Phase)

CTR20140776Phase 3Active

Sponsor
Weihe Pharmaceutical
Start
Oct 2015
Countries
1
01

Overview

A Phase 3 trial of panax notoginseng in brain infarction, sponsored by Weihe Pharmaceutical. Started Oct 2015; status: active.

02

Drugs

panax notoginseng
03

Conditions

brain infarction

Beyond the preview

Go deeper on CTR20140776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call